Tower Research Capital (TRC)’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.5K | Buy |
9,473
+2,907
| +44% | +$14.9K | ﹤0.01% | 2999 |
|
|
2025
Q1 | $9K | Buy |
6,566
+757
| +13% | +$1.04K | ﹤0.01% | 3836 |
|
|
2024
Q4 | $18K | Sell |
5,809
-8,956
| -61% | -$27.7K | ﹤0.01% | 3278 |
|
|
2024
Q3 | $114K | Sell |
14,765
-917
| -6% | -$7.06K | ﹤0.01% | 2131 |
|
|
2024
Q2 | $135K | Buy |
15,682
+14,243
| +990% | +$122K | ﹤0.01% | 2369 |
|
|
2024
Q1 | $11.4K | Sell |
1,439
-11,770
| -89% | -$93.5K | ﹤0.01% | 3567 |
|
|
2023
Q4 | $131K | Buy |
13,209
+11,761
| +812% | +$116K | ﹤0.01% | 2430 |
|
|
2023
Q3 | $16.3K | Sell |
1,448
-1,421
| -50% | -$16K | ﹤0.01% | 3566 |
|
|
2023
Q2 | $9.53K | Sell |
2,869
-10,454
| -78% | -$34.7K | ﹤0.01% | 4241 |
|
|
2023
Q1 | $52K | Buy |
13,323
+10,101
| +314% | +$39.4K | ﹤0.01% | 2462 |
|
|
2022
Q4 | $23K | Sell |
3,222
-18
| -0.6% | -$128 | ﹤0.01% | 3008 |
|
|
2022
Q3 | $12K | Buy |
3,240
+1,028
| +46% | +$3.81K | ﹤0.01% | 4376 |
|
|
2022
Q2 | $10K | Buy |
2,212
+2,112
| +2,112% | +$9.55K | ﹤0.01% | 4487 |
|
|
2022
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 5861 |
|
|
2021
Q4 | – | Sell |
-828
| Closed | -$11K | – | 6566 |
|
|
2021
Q3 | $11K | Buy |
+828
| New | +$11K | ﹤0.01% | 4258 |
|
|
2021
Q2 | – | Sell |
-17
| Closed | – | – | 5844 |
|
|
2021
Q1 | $0 | Buy |
+17
| New | – | ﹤0.01% | 5727 |
|